EGFR and neoplasm: GEM-containing membrane derived from this study demonstrated the ability to promote the Casitas B-lineage lymphoma (c-CBL)-mediated degradation of epidermal growth factor receptor (EGFR) in xenograft tumours, inducing tumour death through the inhibition of their proliferation, angiogenesis, and epithelial-mesenchymal transition.